Good pharma citizenship is more than tree hugging. ESG needs drug pricing input, analysts say

Pharma environment and social goals need to include—the Institute for Clinical and Economic Review (ICER)? They should, one analyst firm says.

The independent drug pricing assessments by ICER could play a role in determining good pharma corporate citizenship, Bernstein analysts say.